{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:47:20Z","timestamp":1793303240943,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RTI 4007"],"award-info":[{"award-number":["RTI 4007"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RTI 4007"],"award-info":[{"award-number":["RTI 4007"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RTI 4007"],"award-info":[{"award-number":["RTI 4007"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RTI 4007"],"award-info":[{"award-number":["RTI 4007"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/005527"],"award-info":[{"award-number":["CRG\/2020\/005527"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Chem"],"DOI":"10.1038\/s42004-025-01524-z","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:02:41Z","timestamp":1746093761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A single fibril study reveals that ApoE inhibits the elongation of A\u03b242 fibrils in an isoform-dependent manner"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-0742","authenticated-orcid":false,"given":"Sourav","family":"Dasadhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamasree","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8584-7022","authenticated-orcid":false,"given":"Sudip","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7879-0140","authenticated-orcid":false,"given":"Tuomas P. J.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-7699","authenticated-orcid":false,"given":"Kanchan","family":"Garai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388, 505\u2013517 (2016).","journal-title":"Lancet"},{"key":"1524_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: An update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"1524_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"1524_CR4","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098\u20138102 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR5","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284\u20131294 (2023).","journal-title":"JAMA Neurol."},{"key":"1524_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis. JAMA-J. Am. Med. Assoc. 278, 1349\u20131356 (1997).","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"1524_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez, G. A., Tai, L. M., LaDu, M. J. & Rebeck, G. W. Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition. J. Neuroinflamm. 11, 111 (2014).","journal-title":"J. Neuroinflamm."},{"key":"1524_CR9","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans, K. L. et al. APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease. J. Biol. Chem. 287, 41774\u201341786 (2012).","journal-title":"J. Biol. Chem."},{"key":"1524_CR10","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med"},{"key":"1524_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe, C. C. et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol. Aging 31, 1275\u20131283 (2010).","journal-title":"Neurobiol. Aging"},{"key":"1524_CR12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","volume":"141","author":"S Mishra","year":"2018","unstructured":"Mishra, S. et al. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE epsilon4 genotype. Brain 141, 1828\u20131839 (2018).","journal-title":"Brain"},{"key":"1524_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg, A. et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging 29, 1456\u20131465 (2008).","journal-title":"Neurobiol. Aging"},{"key":"1524_CR14","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman, E. M. et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. USA 106, 6820\u20136825 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1524_CR16","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu, C. C. et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron 96, 1024\u20131032 e3 (2017).","journal-title":"Neuron"},{"key":"1524_CR17","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales, K. R. et al. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771\u20136779 (2009).","journal-title":"J. Neurosci."},{"key":"1524_CR18","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu, C. C. et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat. Immunol. 24, 1854\u20131866 (2023).","journal-title":"Nat. Immunol."},{"key":"1524_CR19","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz, N. F. et al. Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J. Neurosci. 32, 13125\u201313136 (2012).","journal-title":"J. Neurosci."},{"key":"1524_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T., Xu, H. & Bu, G. ApoE and Abeta in Alzheimer\u2019s disease: Accidental encounters or partners?. Neuron 81, 740\u2013754 (2014).","journal-title":"Neuron"},{"key":"1524_CR21","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1021\/bi5008172","volume":"53","author":"K Garai","year":"2014","unstructured":"Garai, K., Verghese, P. B., Baban, B., Holtzman, D. M. & Frieden, C. The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry 53, 6323\u20136331 (2014).","journal-title":"Biochemistry"},{"key":"1524_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.92.3.763","volume":"92","author":"KC Evans","year":"1995","unstructured":"Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H. & Lansbury, P. T. Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 763\u2013767 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR23","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1111\/febs.14988","volume":"286","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S., Sil, T. B., Dolai, S. & Garai, K. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-b.  FEBS J. 286, 4737\u20134753 (2019).","journal-title":"FEBS J."},{"key":"1524_CR24","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1021\/bi9624705","volume":"36","author":"H Naiki","year":"1997","unstructured":"Naiki, H., Gejyo, F. & Nakakuki, K. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer\u2019s beta-amyloid fibril formation in vitro. Biochemistry 36, 6243\u20136250 (1997).","journal-title":"Biochemistry"},{"key":"1524_CR25","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/cb500994j","volume":"10","author":"S Deroo","year":"2015","unstructured":"Deroo, S. et al. Chemical cross-linking\/mass spectrometry maps the amyloid beta peptide binding region on both apolipoprotein E domains. ACS Chem. Biol. 10, 1010\u20131016 (2015).","journal-title":"ACS Chem. Biol."},{"key":"1524_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/science.1178250","volume":"326","author":"TP Knowles","year":"2009","unstructured":"Knowles, T. P. et al. An analytical solution to the kinetics of breakable filament assembly. Science 326, 1533\u20131537 (2009).","journal-title":"Science"},{"key":"1524_CR27","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen, S. I. et al. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. USA 110, 9758\u20139763 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR28","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1021\/jacs.1c07228","volume":"143","author":"MR Zimmermann","year":"2021","unstructured":"Zimmermann, M. R. et al. Mechanism of Secondary Nucleation at the Single Fibril Level from Direct Observations of Abeta42 Aggregation. J. Am. Chem. Soc. 143, 16621\u201316629 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1524_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","volume":"12","author":"TCT Michaels","year":"2020","unstructured":"Michaels, T. C. T. et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer\u2019s Abeta42 peptide. Nat. Chem. 12, 445\u2013451 (2020).","journal-title":"Nat. Chem."},{"key":"1524_CR30","doi-asserted-by":"publisher","first-page":"110435","DOI":"10.1016\/j.celrep.2022.110435","volume":"38","author":"K Lindner","year":"2022","unstructured":"Lindner, K. et al. Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Rep. 38, 110435 (2022).","journal-title":"Cell Rep."},{"key":"1524_CR31","doi-asserted-by":"publisher","first-page":"e2220664120","DOI":"10.1073\/pnas.2220664120","volume":"120","author":"D Thacker","year":"2023","unstructured":"Thacker, D., Barghouth, M., Bless, M., Zhang, E. & Linse, S. Direct observation of secondary nucleation along the fibril surface of the amyloid beta 42 peptide. Proc. Natl. Acad. Sci. USA 120, e2220664120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23507-z","volume":"12","author":"L Amin","year":"2021","unstructured":"Amin, L. & Harris, D. A. Abeta receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat. Commun. 12, 3451 (2021).","journal-title":"Nat. Commun."},{"key":"1524_CR33","doi-asserted-by":"publisher","first-page":"27987","DOI":"10.1039\/C7CP03412A","volume":"19","author":"LJ Young","year":"2017","unstructured":"Young, L. J., Kaminski Schierle, G. S. & Kaminski, C. F. Imaging Abeta(1-42) fibril elongation reveals strongly polarised growth and growth incompetent states. Phys. Chem. Chem. Phys. 19, 27987\u201327996 (2017).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"1524_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41592-019-0451-6","volume":"16","author":"M Franzl","year":"2019","unstructured":"Franzl, M. et al. Thermophoretic trap for single amyloid fibril and protein aggregation studies. Nat. Methods 16, 611\u2013614 (2019).","journal-title":"Nat. Methods"},{"key":"1524_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan, A. M. et al. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 9, 305\u2013318 (2002).","journal-title":"Neurobiol. Dis."},{"key":"1524_CR36","doi-asserted-by":"publisher","first-page":"e1700488","DOI":"10.1126\/sciadv.1700488","volume":"3","author":"FA Aprile","year":"2017","unstructured":"Aprile, F. A. et al. Selective targeting of primary and secondary nucleation pathways in Abeta42 aggregation using a rational antibody scanning method. Sci. Adv. 3, e1700488 (2017).","journal-title":"Sci. Adv."},{"key":"1524_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nprot.2016.010","volume":"11","author":"G Meisl","year":"2016","unstructured":"Meisl, G. et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat. Protoc. 11, 252\u2013272 (2016).","journal-title":"Nat. Protoc."},{"key":"1524_CR38","doi-asserted-by":"publisher","first-page":"065105","DOI":"10.1063\/1.3608916","volume":"135","author":"SI Cohen","year":"2011","unstructured":"Cohen, S. I. et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J. Chem. Phys. 135, 065105 (2011).","journal-title":"J. Chem. Phys."},{"key":"1524_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50692-4","volume":"15","author":"CK Xu","year":"2024","unstructured":"Xu, C. K. et al. alpha-Synuclein oligomers form by secondary nucleation. Nat. Commun. 15, 7083 (2024).","journal-title":"Nat. Commun."},{"key":"1524_CR40","doi-asserted-by":"publisher","first-page":"e2401307122","DOI":"10.1073\/pnas.2401307122","volume":"122","author":"G Sneideriene","year":"2025","unstructured":"Sneideriene, G. et al. Lipid-induced condensate formation from the Alzheimer\u2019s Abeta peptide triggers amyloid aggregation. Proc. Natl. Acad. Sci. USA 122, e2401307122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR41","doi-asserted-by":"publisher","first-page":"140535","DOI":"10.1016\/j.bbapap.2020.140535","volume":"1868","author":"S Dolai","year":"2020","unstructured":"Dolai, S., Cherakara, S. & Garai, K. Apolipoprotein E4 exhibits intermediates with domain interaction. Biochim Biophys. Acta Proteins Proteom. 1868, 140535 (2020).","journal-title":"Biochim Biophys. Acta Proteins Proteom."},{"key":"1524_CR42","doi-asserted-by":"crossref","unstructured":"Dolai, S., Pal, S., Deepa, S. & Garai, K. Quantitative assessment of conformational heterogeneity in apolipoprotein E4 using hydrogen-deuterium exchange mass spectrometry. J. Phys. Chem. B 128, 10075\u201310085 (2024).","DOI":"10.1021\/acs.jpcb.4c04738"},{"key":"1524_CR43","doi-asserted-by":"publisher","first-page":"108101","DOI":"10.1103\/PhysRevLett.94.108101","volume":"94","author":"M Bates","year":"2005","unstructured":"Bates, M., Blosser, T. R. & Zhuang, X. Short-range spectroscopic ruler based on a single-molecule optical switch. Phys. Rev. Lett. 94, 108101 (2005).","journal-title":"Phys. Rev. Lett."},{"key":"1524_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ymeth.2014.01.010","volume":"67","author":"H Zhang","year":"2014","unstructured":"Zhang, H. & Guo, P. Single molecule photobleaching (SMPB) technology for counting of RNA, DNA, protein and other molecules in nanoparticles and biological complexes by TIRF instrumentation. Methods 67, 169\u2013176 (2014).","journal-title":"Methods"},{"key":"1524_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10948","volume":"7","author":"P Arosio","year":"2016","unstructured":"Arosio, P. et al. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat. Commun. 7, 10948 (2016).","journal-title":"Nat. Commun."},{"key":"1524_CR46","doi-asserted-by":"publisher","first-page":"16858","DOI":"10.1074\/jbc.M117.789990","volume":"292","author":"E Bove-Fenderson","year":"2017","unstructured":"Bove-Fenderson, E., Urano, R., Straub, J. E. & Harris, D. A. Cellular prion protein targets amyloid-beta fibril ends via its C-terminal domain to prevent elongation. J. Biol. Chem. 292, 16858\u201316871 (2017).","journal-title":"J. Biol. Chem."},{"key":"1524_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-23","volume":"11","author":"DA Elliott","year":"2010","unstructured":"Elliott, D. A., Halliday, G. M. & Garner, B. Apolipoprotein-E forms dimers in human frontal cortex and hippocampus. BMC Neurosci. 11, 23 (2010).","journal-title":"BMC Neurosci."},{"key":"1524_CR48","doi-asserted-by":"publisher","first-page":"e2220075121","DOI":"10.1073\/pnas.2220075121","volume":"121","author":"S Curk","year":"2024","unstructured":"Curk, S. et al. Self-replication of Abeta(42) aggregates occurs on small and isolated fibril sites. Proc. Natl. Acad. Sci. USA 121, e2220075121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR49","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1021\/bi9626362","volume":"36","author":"S Aleshkov","year":"1997","unstructured":"Aleshkov, S., Abraham, C. R. & Zannis, V. I. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer\u2019s disease. Biochemistry 36, 10571\u201310580 (1997).","journal-title":"Biochemistry"},{"key":"1524_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"SF Lau","year":"2023","unstructured":"Lau, S. F. et al. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat. Aging 3, 1219\u20131236 (2023).","journal-title":"Nat. Aging"},{"key":"1524_CR51","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane, R. et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest 118, 4002\u20134013 (2008).","journal-title":"J. Clin. Invest"},{"key":"1524_CR52","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"1524_CR53","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho, M. et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10, 719\u2013726 (2004).","journal-title":"Nat. Med."},{"key":"1524_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh, M., Korczyn, A. D. & Michaelson, D. M. ApoE4: An emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 17, 64 (2019).","journal-title":"BMC Med."},{"key":"1524_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49028-z","volume":"15","author":"Z Xia","year":"2024","unstructured":"Xia, Z. et al. Co-aggregation with Apolipoprotein E modulates the function of Amyloid-beta in Alzheimer\u2019s disease. Nat. Commun. 15, 4695 (2024).","journal-title":"Nat. Commun."},{"key":"1524_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen, S. I. A. et al. A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers. Nat. Struct. Mol. Biol. 22, 207\u2013213 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1524_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"1524_CR58","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41594-020-0471-z","volume":"27","author":"P Flagmeier","year":"2020","unstructured":"Flagmeier, P. et al. Direct measurement of lipid membrane disruption connects kinetics and toxicity of Abeta42 aggregation. Nat. Struct. Mol. Biol. 27, 886\u2013891 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1524_CR59","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin, M. et al. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. USA 108, 5819\u20135824 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1524_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"1524_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway, S. et al. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease. JAMA Neurol. 79, 13\u201321 (2022).","journal-title":"JAMA Neurol."},{"key":"1524_CR62","doi-asserted-by":"crossref","unstructured":"Cadiz, M. P. et al. Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. J. Exp. Med. 221, e20231363 (2024).","DOI":"10.1084\/jem.20231363"},{"key":"1524_CR63","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41594-020-0505-6","volume":"27","author":"S Linse","year":"2020","unstructured":"Linse, S. et al. Kinetic fingerprints differentiate the mechanisms of action of anti-Abeta antibodies. Nat. Struct. Mol. Biol. 27, 1125\u20131133 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1524_CR64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","volume":"36","author":"A Lord","year":"2009","unstructured":"Lord, A. et al. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 36, 425\u2013434 (2009).","journal-title":"Neurobiol. Dis."},{"key":"1524_CR65","doi-asserted-by":"publisher","first-page":"103949","DOI":"10.1016\/j.mcn.2024.103949","volume":"130","author":"M Johannesson","year":"2024","unstructured":"Johannesson, M. et al. Lecanemab demonstrates highly selective binding to Abeta protofibrils isolated from Alzheimer\u2019s disease brains. Mol. Cell Neurosci. 130, 103949 (2024).","journal-title":"Mol. Cell Neurosci."},{"key":"1524_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1524_CR67","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00259-023-06177-5","volume":"50","author":"A Verger","year":"2023","unstructured":"Verger, A. et al. FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective. Eur. J. Nucl. Med. Mol. Imaging 50, 1553\u20131555 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1524_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1134-4","volume":"15","author":"S Sollvander","year":"2018","unstructured":"Sollvander, S. et al. The Abeta protofibril selective antibody mAb158 prevents accumulation of Abeta in astrocytes and rescues neurons from Abeta-induced cell death. J. Neuroinflamm. 15, 98 (2018).","journal-title":"J. Neuroinflamm."},{"key":"1524_CR69","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self, W. K. & Holtzman, D. M. Emerging diagnostics and therapeutics for Alzheimer disease. Nat. Med. 29, 2187\u20132199 (2023).","journal-title":"Nat. Med."},{"key":"1524_CR70","doi-asserted-by":"crossref","unstructured":"Xiong, M. et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci. Transl. Med. 13, eabd7522 (2021).","DOI":"10.1126\/scitranslmed.abd7522"},{"key":"1524_CR71","doi-asserted-by":"crossref","unstructured":"Franco, A. et al. All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of alpha-synuclein toxic species. Proc. Natl. Acad. Sci. USA 118, e2105548118 (2021).","DOI":"10.1073\/pnas.2105548118"},{"key":"1524_CR72","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."}],"container-title":["Communications Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01524-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01524-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01524-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:35:16Z","timestamp":1746520516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01524-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1038\/s42004-025-01524-z","relation":{},"ISSN":["2399-3669"],"issn-type":[{"value":"2399-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}